Back to Search
Start Over
Abnormal carnitine metabolism in hemodialysis patients on different anticoagulants.
- Source :
- Therapeutic Apheresis & Dialysis; Jun2024, Vol. 28 Issue 3, p364-370, 7p
- Publication Year :
- 2024
-
Abstract
- Introduction: We aimed to determine whether unfractionated heparin (UH) and low molecular weight heparin (LH) contribute to aberrant carnitine metabolism in patients receiving hemodialysis. Methods: The rate of increase in serum free fatty acids (FFAs) and the ratio of acylcarnitine to free carnitine (AC/FC) from before to after hemodialysis were determined in patients receiving UH and LH. Additionally, the effect of switching patients to UH from LH was examined. Results: AC/FC was significantly higher in the UH group. In addition, serum FFAs in that group increased to 0.825 ± 0.270 after dialysis from 0.172 ± 0.160 before dialysis, showing a positive correlation with AC/FC. Furthermore, AC/FC was observed to be significantly higher in patients who were switched to UH from LH at 3 months after the change. Conclusion: Compared with UH, LH has a lesser effect on lipid metabolism, suggesting that it also has a lesser effect on carnitine metabolism. [ABSTRACT FROM AUTHOR]
Details
- Language :
- English
- ISSN :
- 17449979
- Volume :
- 28
- Issue :
- 3
- Database :
- Complementary Index
- Journal :
- Therapeutic Apheresis & Dialysis
- Publication Type :
- Academic Journal
- Accession number :
- 176866882
- Full Text :
- https://doi.org/10.1111/1744-9987.14096